Joyce J. Lee Joins Phibro Animal Health Corporation's Board
TEANECK, N.J. — The Board of Directors of Phibro Animal Health Corporation (NASDAQ: PAHC) has exciting news: Joyce J. Lee, MBA, has been appointed as a Class II director of the Company, effective immediately. This important addition to the Board fills a current vacancy, bringing the total number of directors to nine, with six being independent members.
Bringing a Wealth of Experience
Ms. Lee comes to Phibro with a remarkable background in the animal health industry. Her most recent role was as President of Cobb Vantress LLC, a frontrunner in animal genetics dedicated to sustainable practices. Her past significant positions at esteemed companies like Elanco, Bayer Animal Health, and Zoetis have equipped her with diverse skills in management across various levels, enriching her with executive leadership experience.
History of Leadership
Throughout her career, Joyce Lee has made substantial contributions in global genetics production, management, strategy formulation, and optimizing marketing procedures. Her work often intersects several key areas, including outcomes research, research and development, engineering, and IT which have proven invaluable to the companies she has served. In recognition of her contributions in 2018, she was honored with the distinguished Feather in Her Cap Award, validating her status as a leader within the industry.
What She Brings to the Board
Joyce’s qualifications extend beyond her experience; they encompass strategic vision and comprehensive operational expertise. Her knowledge of public company governance also adds to her suitability as a Board member, having served on both the corporate governance and nomination committee, as well as the audit committee for a publicly traded company for over five years.
Strong Leadership Vision
Joyce’s educational background supplements her impressive professional qualifications. She holds a Bachelor's Degree in Business Administration from Baylor University along with an MBA in Healthcare Administration from Jacksonville University.
Welcoming Joyce Lee
Phibro’s Chairman, President, and CEO, Jack Bendheim expressed enthusiasm for Joyce's appointment: “We are very much looking forward to working with Joyce. Her proven ability to drive value creation across leading animal health brands in beef, dairy, swine, and aquaculture, combined with her understanding of the pet care sector, makes her an excellent addition to our Board of Directors.”
About Phibro Animal Health Corporation
Phibro Animal Health Corporation excels as a leading global diversified animal health and mineral nutrition company. Our mission is to serve as a reliable partner to livestock producers, farmers, veterinarians, and animal caregivers, providing innovative solutions aimed at enhancing animal health.
Frequently Asked Questions
What is the significance of Joyce J. Lee’s appointment?
Joyce J. Lee's appointment strengthens Phibro's Board with her extensive experience in the animal health sector, essential for guiding the Company's strategic vision.
What positions has Joyce held prior to joining Phibro?
Joyce served as President of Cobb Vantress LLC and held executive roles at Elanco, Bayer Animal Health, and Zoetis, demonstrating her leadership across various companies.
What expertise does Joyce bring to the Board of Directors?
She brings expertise in animal health management, marketing strategies, and global genetics production, along with public company governance experience.
What is Phibro Animal Health Corporation's focus?
Phibro is dedicated to providing animal health solutions to livestock producers and veterinarians, ensuring the well-being of farm and companion animals.
How many members are on Phibro’s Board after this appointment?
With this appointment, the Board consists of nine members, six of whom are independent directors, enhancing its governance structure.
